https://www.nasdaq.com/press-release/apollo-endosurgery-announces-new-%24100-million-senior-secured-term-loan-facility-from
https://www.nasdaq.com/press-release/apollo-endosurgery-to-present-at-four-upcoming-investor-conferences-2021-11-12
https://www.nasdaq.com/press-release/apollo-endosurgery-inc.-reports-28-revenue-growth-in-third-quarter-conference-call
https://www.nasdaq.com/press-release/apollo-endosurgery-announces-publication-of-a-multicenter-study-of-its-x
https://www.nasdaq.com/press-release/apollo-endosurgery-to-report-third-quarter-financial-results-on-november-1-2021-2021
https://www.nasdaq.com/press-release/apollo-endosurgery-announces-positive-merit-trial-outcomes-2021-10-22
https://www.nasdaq.com/press-release/apollo-endosurgery-announces-closing-of-public-offering-and-exercise-in-full-of
https://www.nasdaq.com/press-release/apollo-endosurgery-announces-pricing-of-%2465-million-public-offering-of-common-stock
https://www.nasdaq.com/press-release/apollo-endosurgery-announces-commencement-of-public-offering-of-common-stock-2021-10
https://www.nasdaq.com/press-release/apollo-endosurgery-announces-preliminary-third-quarter-2021-financial-results-and
https://www.nasdaq.com/press-release/apollo-endosurgery-to-present-at-lake-streets-5th-annual-best-ideas-growth-conference
https://www.nasdaq.com/press-release/apollo-endosurgery-inc.-reports-record-endoscopy-revenue-in-second-quarter-raises
https://www.nasdaq.com/press-release/apollo-endosurgery-to-report-second-quarter-financial-results-on-august-3-2021-2021
https://www.nasdaq.com/press-release/apollo-endosurgery-appoints-jeffrey-g.-black-as-chief-financial-officer-2021-07-16
https://www.nasdaq.com/press-release/merit-study-investigators-announce-successful-achievement-of-the-studys-primary
https://www.nasdaq.com/press-release/apollo-endosurgery-to-present-at-june-investor-conferences-2021-06-01
https://www.nasdaq.com/press-release/apollo-endosurgerys-innovative-overstitchtm-endoscopic-suturing-system-highlighted
https://www.nasdaq.com/press-release/sidoti-microcap-virtual-conference-2021-05-18
https://www.nasdaq.com/press-release/apollo-endosurgery-to-present-at-sidoti-conference-may-20-2021-05-12
https://www.nasdaq.com/press-release/apollo-endosurgery-inc.-reports-29-increase-in-first-quarter-revenue-2021-05-13
https://www.nasdaq.com/press-release/apollo-endosurgery-announces-appointments-to-commercial-leadership-team-2021-05-03
https://www.nasdaq.com/press-release/apollo-endosurgery-to-report-first-quarter-financial-results-on-may-4-2021-2021-04-28
https://www.nasdaq.com/press-release/apollo-endosurgery-announces-publication-of-pre-clinical-results-for-x-tacktm
https://www.nasdaq.com/press-release/apollo-endosurgery-announces-inducement-grant-2021-03-19
https://www.nasdaq.com/press-release/apollo-endosurgery-announces-ama-assignment-of-category-i-cpt-codes-for-use-in
https://www.nasdaq.com/press-release/apollo-endosurgery-to-present-at-hc-wainwright-global-life-sciences-conference-2021
https://www.nasdaq.com/press-release/apollo-endosurgery-receives-fda-breakthrough-device-designation-for-the-orberar
https://www.nasdaq.com/press-release/apollo-endosurgery-inc.-reports-fourth-quarter-and-full-year-2020-results-2021-02-25
https://www.nasdaq.com/press-release/apollo-endosurgery-to-report-fourth-quarter-and-full-year-2020-financial-results-on
https://www.nasdaq.com/press-release/apollo-endosurgery-announces-ceo-transition-2021-02-08
https://www.nasdaq.com/press-release/apollo-endosurgery-to-present-at-hc-wainwright-bioconnect-conference-2021-01-05
https://www.nasdaq.com/press-release/apollo-endosurgery-receives-fda-clearance-for-the-x-tacktm-endoscopic-helix-tacking
https://www.nasdaq.com/press-release/apollo-endosurgery-extends-maturity-date-on-senior-secured-term-loan-and-convertible
https://www.nasdaq.com/press-release/apollo-endosurgery-to-present-at-piper-sandler-healthcare-conference-2020-11-23
https://www.nasdaq.com/press-release/apollo-endosurgery-inc.-reports-third-quarter-2020-results-2020-11-05
https://www.nasdaq.com/press-release/apollo-endosurgery-to-present-at-november-investor-conferences-2020-11-03
https://www.nasdaq.com/press-release/apollo-endosurgery-inc.-to-report-third-quarter-2020-results-on-november-5-2020-2020
https://www.nasdaq.com/press-release/apollo-endosurgery-to-present-at-hc-wainwright-conference-2020-09-11
https://www.nasdaq.com/press-release/ld-micro-360-companies-set-to-present-this-week-2020-08-31
https://www.nasdaq.com/press-release/apollo-endosurgery-to-present-at-the-ld-500-virtual-conference-2020-08-26
https://www.nasdaq.com/press-release/ld-micro-announces-preliminary-list-of-presenters-for-the-ld-500-2020-08-05
https://www.nasdaq.com/press-release/apollo-endosurgery-inc.-reports-second-quarter-2020-results-2020-08-04
https://www.nasdaq.com/press-release/apollo-endosurgery-inc.-to-report-second-quarter-2020-results-on-august-4-2020-2020
https://www.nasdaq.com/press-release/apollo-endosurgery-announces-%2425-million-equity-financing-solar-loan-amendment-and
https://www.nasdaq.com/press-release/apollo-endosurgery-announces-510k-submission-for-the-x-tacktm-endoscopic-helix
https://www.nasdaq.com/press-release/apollo-endosurgery-inc.-reports-first-quarter-2020-results-2020-05-04
https://www.nasdaq.com/press-release/apollo-endosurgery-inc.-to-report-first-quarter-2020-results-on-may-4-2020-2020-04-30
https://www.nasdaq.com/press-release/apollo-endosurgery-announces-completion-of-the-us-post-approval-study-for-the-orberar
https://www.nasdaq.com/press-release/apollo-endosurgery-inc.-reports-fourth-quarter-and-full-year-2019-results-2020-03-26
https://www.nasdaq.com/press-release/apollo-endosurgery-inc.-to-report-fourth-quarter-and-full-year-2019-results-on-march
https://www.nasdaq.com/press-release/apollo-endosurgery-inc.-to-present-at-the-12th-annual-ld-micro-conference-2019-12-02
https://www.nasdaq.com/press-release/apollo-endosurgery-inc.-to-present-at-the-31st-annual-piper-jaffray-healthcare
